The 10th Conference on Cancer therapy with Antibodies and Immunoconjugates
Last Modified: April 14, 2004
Conference Dates: October 21-23, 2004
Conference Location: Princeton, NJ
Sponsoring Group: Imedex, Inc.
Conference Web Page URL: www.imedex.com/calendars/oncology.htm
Registration Information: Online at www.imedex.com; Tel: +1 770 751 7332; Fax: +1 770 751 7334; Email: firstname.lastname@example.org
Continuing Education: Yes
ASCO: Combo Antibody Therapy Effective for Melanoma
May 20, 2013 - Concurrent use of two immune checkpoint antibodies -- ipilimumab and nivolumab -- may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in advance of the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
Frequently Asked Questions
National Cancer Institute
I Wish You Knew
How cancer patients have changed my life
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!